Frank Neumann

Frank Neumann currently serves as Chief Medical Officer and Board Member at Orna Therapeutics, a position held since October 2023. Additionally, Frank Neumann is an Entrepreneur Partner at MPM BioImpact from April 2024. Previously, Frank Neumann held various prominent roles, including Senior Vice President and Global Head of Clinical Development at Kite Pharma (February 2021 - May 2024), Chief Medical Officer at Verastem Oncology (January 2021 - February 2021), and Vice President and Head of Oncology Clinical Research at Bluebird Bio (July 2019 - January 2021). Frank Neumann's experience includes leadership positions in clinical development at Takeda Oncology and Takeda, and senior roles at AstraZeneca and sanofi-aventis, focusing on key oncology programs and clinical studies. Frank Neumann began a research role as a Research Scholar at MD Anderson Cancer Center in early 2010.